These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1517635)

  • 1. Transdermal fentanyl use in hospice home-care patients with chronic cancer pain.
    Herbst LH; Strause LG
    J Pain Symptom Manage; 1992 Apr; 7(3 Suppl):S54-7. PubMed ID: 1517635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl transdermal system. Pain management at home.
    Woodroffe MA; Hays H
    Can Fam Physician; 1997 Feb; 43():268-72. PubMed ID: 9040914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cancer pain with transdermal fentanyl: phase IV trial, University of Iowa.
    Maves TJ; Barcellos WA
    J Pain Symptom Manage; 1992 Apr; 7(3 Suppl):S58-62. PubMed ID: 1517636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal fentanyl: seeding trial in patients with chronic cancer pain.
    Levy MH; Rosen SM; Kedziera P
    J Pain Symptom Manage; 1992 Apr; 7(3 Suppl):S48-50. PubMed ID: 1517633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center.
    Slover R
    J Pain Symptom Manage; 1992 Apr; 7(3 Suppl):S45-7. PubMed ID: 1517632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose fentanyl patch for cancer pain.
    Menahem S; Shvartzman P
    J Am Board Fam Pract; 2004; 17(5):388-90. PubMed ID: 15355954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal fentanyl: long-term analgesic studies.
    Simmonds MA; Richenbacher J
    J Pain Symptom Manage; 1992 Apr; 7(3 Suppl):S36-9. PubMed ID: 1517630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination.
    Iconomou G; Viha A; Vagenakis AG; Kalofonos HP
    Anticancer Res; 2000; 20(6C):4821-4. PubMed ID: 11205226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.
    Allan L; Hays H; Jensen NH; de Waroux BL; Bolt M; Donald R; Kalso E
    BMJ; 2001 May; 322(7295):1154-8. PubMed ID: 11348910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
    Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
    Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
    Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain.
    Kang JH; Oh SY; Song SY; Lee HY; Kim JH; Lee KE; Lee HR; Hwang IG; Park SH; Kim WS; Park YS; Park K
    Korean J Intern Med; 2015 Jan; 30(1):88-95. PubMed ID: 25589840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal fentanyl for chronic cancer pain: detailed case reports and the influence of confounding factors.
    Patt RB; Hogan LA
    J Pain Symptom Manage; 1992 Apr; 7(3 Suppl):S51-3. PubMed ID: 1517634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal fentanyl for pain control in patients with cancer.
    Miser AW; Narang PK; Dothage JA; Young RC; Sindelar W; Miser JS
    Pain; 1989 Apr; 37(1):15-21. PubMed ID: 2726274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High transdermal fentanyl requirements in a patient with chronic cancer pain.
    Lehr VT; Renaud EA
    Ann Pharmacother; 1993 May; 27(5):575-8. PubMed ID: 8347906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
    Muijsers RB; Wagstaff AJ
    Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
    Berliner MN; Giesecke T; Bornhövd KD
    Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.